Biocartis SA-Medical Equipment-Deals and Alliances Profile

Biocartis SA-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME194956D
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biocartis SA (Biocartis) is a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its Idylla is a molecular diagnostics system that provides easy access to clinical molecular diagnostic information. Biocartis also offers a wide range of oncology assays such as Idylla BRAF Mutation Test, Idylla KRAS Mutation Test, Idylla EGFR Mutation Test and Idylla NRAS Mutation. The company has partnership with Johnson & Johnson, and Abbot to develop diagnostics tests in other disease areas. It also has operations in Belgium. Biocartis is headquartered in Lausanne, Switzerland.

Biocartis SA-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Biocartis SA, Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Biocartis SA, Medical Equipment Deals By Type, 2010 to YTD 2016 6

Biocartis SA, Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Biocartis SA, Medical Equipment, Deals By Market, 2010 to YTD 2016 8

Biocartis SA, Medical Equipment, Deals Summary, 2010 to YTD 2016 9

Biocartis SA, Medical Equipment, Deal Details 11

Asset Purchase 11

Biocartis Completes Acquisition Of Molecular Diagnostic Technology From Royal Philips Electronics 11

Venture Financing 12

Biocartis Raises USD85 Million in Venture Financing 12

Biocartis Raises US$40.5 Million In Series E Financing 14

Biocartis Raises US$44.7 Million In Series D Financing 16

Biocartis Secures US$96 Million In Series C Financing Round 18

Biocartis Secures US$41.3 Million In Series B Financing Round 20

Partnerships 22

Biocartis Enters into Licensing and Development Agreement with Microbiome 22

Biocartis And VIB Enter Into Licensing Agreement To Develop Diagnostic Cancer Test 23

Biocartis Enters Into Licensing Agreement With Hospital del Mar 24

Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 25

Biocartis Enters into Agreement with Amgen 27

Merck to Enter into Co-Development Agreement with Biocartis 28

Biocartis Enters into Co-Development Agreement with Fast-track diagnostics 29

Biocartis Forms Joint Venture with Pronota 30

Abbott Molecular Enters into Co-Development Agreement with Biocartis 31

Invetech Enters Into Co-Development Agreement With Biocartis For Evalution 32

Biocartis Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Philips Research Europe For Oncology Diagnostics 33

Biocartis Enters Into Co-Development Agreement With Janssen Pharmaceutica 34

Biomerieux Enters Into Co-Development Agreement With Biocartis 35

Equity Offering 36

Biocartis Completes Exercise of Over-Allotment Option of IPO of Shares for USD122 Million 36

Biocartis SA-Key Competitors 37

Key Employees 38

Locations And Subsidiaries 39

Head Office 39

Other Locations & Subsidiaries 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

Biocartis SA, Medical Equipment, Deals by Type, 2010 to YTD 2016 1

Biocartis SA, Medical Equipment, Deals By Year, 2010 to YTD 2016 1

Biocartis SA, Medical Equipment, Deals By Region, 2010 to YTD 2016 1

Biocartis SA, Medical Equipment, Deals By Market, 2010 to YTD 2016 1

Biocartis SA, Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Biocartis SA, Medical Equipment, Deals by Type, 2010 to YTD 2016 6

Biocartis SA, Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Biocartis SA, Medical Equipment, Deals by Market, 2010 to YTD 2016 8

List of Tables

Biocartis SA, Medical Equipment, Key Facts 1

Biocartis SA, Medical Equipment, Deals Summary, 2010 to YTD 2016 1

Biocartis SA, Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Biocartis SA, Medical Equipment Deals By Type, 2010 to YTD 2016 6

Biocartis SA, Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Biocartis SA, Deals By Market, 2010 to YTD 2016 8

Biocartis SA, Medical Equipment, Deals Summary, 2010 to YTD 2016 9

Biocartis Completes Acquisition Of Molecular Diagnostic Technology From Royal Philips Electronics 11

Biocartis Raises USD85 Million in Venture Financing 12

Biocartis Raises US$40.5 Million In Series E Financing 14

Biocartis Raises US$44.7 Million In Series D Financing 16

Biocartis Secures US$96 Million In Series C Financing Round 18

Biocartis Secures US$41.3 Million In Series B Financing Round 20

Biocartis Enters into Licensing and Development Agreement with Microbiome 22

Biocartis And VIB Enter Into Licensing Agreement To Develop Diagnostic Cancer Test 23

Biocartis Enters Into Licensing Agreement With Hospital del Mar 24

Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 25

Biocartis Enters into Agreement with Amgen 27

Merck to Enter into Co-Development Agreement with Biocartis 28

Biocartis Enters into Co-Development Agreement with Fast-track diagnostics 29

Biocartis Forms Joint Venture with Pronota 30

Abbott Molecular Enters into Co-Development Agreement with Biocartis 31

Invetech Enters Into Co-Development Agreement With Biocartis For Evalution 32

Biocartis Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Philips Research Europe For Oncology Diagnostics 33

Biocartis Enters Into Co-Development Agreement With Janssen Pharmaceutica 34

Biomerieux Enters Into Co-Development Agreement With Biocartis 35

Biocartis Completes Exercise of Over-Allotment Option of IPO of Shares for USD122 Million 36

Biocartis SA, Key Competitors 37

Biocartis SA, Key Employees 38

Biocartis SA, Subsidiaries 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Biocartis SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16235
Site License
USD 500 INR 32470
Corporate User License
USD 750 INR 48705

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com